AbbVie Inc. SEC filings ABBV
AbbVie Inc. has 1,006 filings in SEC EDGAR's recent list, going back to May 9, 2017. Its latest annual report, Form ARS, was filed on Mar 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 2, 2026 (officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B5 | Prospectus supplement | Aug 6, 2026 | — |
| FWP | Free writing prospectus | Aug 5, 2026 | — |
| 424B5 | Prospectus supplement | Aug 4, 2026 | — |
| 424B5 | Prospectus supplement | Feb 26, 2026 | — |
| FWP | Free writing prospectus | Feb 26, 2026 | — |
| FWP | Free writing prospectus | Feb 25, 2026 | — |
| 424B5 | Prospectus supplement | Feb 24, 2026 | — |
| 424B5 | Prospectus supplement | Feb 20, 2025 | — |
| FWP | Free writing prospectus | Feb 19, 2025 | — |
| 424B5 | Prospectus supplement | Feb 18, 2025 | — |
| S-3ASR | Automatic shelf registration | Feb 14, 2025 | — |
| S-8 | Employee stock plan registration | Nov 4, 2024 | — |
| S-8 | Employee stock plan registration | Nov 4, 2024 | — |
| S-8 | Employee stock plan registration | Aug 14, 2024 | — |
| 424B5 | Prospectus supplement | Feb 26, 2024 | — |
| FWP | Free writing prospectus | Feb 23, 2024 | — |
| S-8 | Employee stock plan registration | Feb 23, 2024 | — |
| 424B5 | Prospectus supplement | Feb 21, 2024 | — |
| S-8 POS | Filing | Jun 9, 2023 | — |
| S-8 | Employee stock plan registration | Nov 4, 2022 | — |
| S-3ASR | Automatic shelf registration | Feb 22, 2022 | — |
| S-8 | Employee stock plan registration | May 12, 2021 | — |
| 424B3 | Prospectus | Oct 19, 2020 | — |
| S-4 | Registration for a merger or exchange | Oct 2, 2020 | — |
| S-8 | Employee stock plan registration | Jun 19, 2020 | — |
| S-3ASR | Automatic shelf registration | May 15, 2020 | — |
| 424B5 | Prospectus supplement | Sep 19, 2019 | — |
| FWP | Free writing prospectus | Sep 17, 2019 | — |
| 424B3 | Prospectus | Sep 16, 2019 | — |
| 424B5 | Prospectus supplement | Sep 17, 2018 | — |
| FWP | Free writing prospectus | Sep 14, 2018 | — |
| 424B5 | Prospectus supplement | Sep 13, 2018 | — |
| S-3ASR | Automatic shelf registration | Sep 13, 2018 | — |
| S-8 | Employee stock plan registration | Dec 15, 2017 | — |
| S-8 | Employee stock plan registration | Dec 15, 2017 | — |
Showing 35 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ABBV (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- North Chicago, IL
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1551152
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
- Pfizer Inc PFE
Source: SEC EDGAR filings. This is company-reported data, not investment advice.